| Zeit | Aktuelle Nachrichten Sprache: 
Alle DE EN  | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Modular Medical validiert Produktionslinie für Pivot-Controller vor geplanter Markteinführung 2026 | 1 | Investing.com Deutsch | ||
| Mo | Modular Medical, Inc.: Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System | 375 | ACCESS Newswire | Key Highlights:Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless... ► Artikel lesen  | |
| 28.10. | Modular Medical, Inc.: Modular Medical Announces Ongoing Progress to Obtain CE Mark | 203 | ACCESS Newswire | Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026 SAN DIEGO, CA / ACCESS Newswire / October 28, 2025 / Modular... ► Artikel lesen  | |
| 06.10. | Modular Medical appoints David Bosshard to lead international expansion | 3 | Investing.com | ||
| 06.10. | Modular Medical, Inc.: Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System | 193 | ACCESS Newswire | -Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA / ACCESS Newswire / October 6, 2025 /... ► Artikel lesen  | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 29.09. | Modular Medical raises $4.4M through warrant exercise and issues new warrants | 2 | Seeking Alpha | ||
| 29.09. | Modular Medical sichert sich 4,4 Millionen Dollar durch Ausübung von Optionsscheinen | 3 | Investing.com Deutsch | ||
| 29.09. | Modular Medical, Inc.: Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds | 227 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion... ► Artikel lesen  | |
| 23.09. | Modular Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.09. | Modular Medical, Inc.: Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study | 188 | ACCESS Newswire | -Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or... ► Artikel lesen  | |
| 11.09. | Modular Medical, Inc.: Modular Medical Announces Completion of Clinical Study of MODD1 Pump | 958 | ACCESS Newswire | - Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery... ► Artikel lesen  | |
| 27.08. | Modular Medical gets insulin pump cartridge production ready for commercial activity | 3 | MassDevice | ||
| 26.08. | Modular Medical, Inc.: Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion | 640 | ACCESS Newswire | -More than 6,000 MODD1 cartridges produced- Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc.... ► Artikel lesen  | |
| 11.08. | Modular Medical unveils next-gen insulin patch pump, expects FDA submission this fall | 1 | MassDevice | ||
| 08.08. | Modular Medical, Inc.: Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration | 494 | ACCESS Newswire | -Debuting a "coming soon" campaign for tubeless Pivot patch pump- Expects special 510(k) filing for Pivot product in October- Will introduce first level of its gamified training application developed... ► Artikel lesen  | |
| 06.08. | Modular Medical, Inc.: Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin | 394 | ACCESS Newswire | - Use of MODD1 on clinician with Type 1 diabetes- Modular Medical intends to deploy the MODD1 on a larger number of clinicians in mid August SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular... ► Artikel lesen  | |
| 04.08. | Modular Medical, Inc.: Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production | 173 | ACCESS Newswire | -Line has been in production at risk since early July- Production to continue until late August when conversion to Pivot manufacturing will begin SAN DIEGO, CA / ACCESS Newswire / August 4, 2025 / Modular... ► Artikel lesen  | |
| 02.07. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.06. | Modular Medical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 16.06. | Modular Medical, Inc.: Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions | 242 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump... ► Artikel lesen  | 
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 45,670 | -1,91 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG 
 / Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen  | |
| FRESENIUS | 49,270 | -1,50 % | DAX-Check LIVE: Fresenius, Nordex, Rheinmetall, SAP, Siltronic, Symrise im Fokus | Trotz freundlicher Vorgaben wollte am deutschen Aktienmarkt auch heute keine echte Euphorie aufkommen. Die Anleger zeigten sich abwartend. Nach anfänglichen leichten Gewinnen rutschte der DAX zunächst... ► Artikel lesen  | |
| SIEMENS HEALTHINEERS | 48,820 | +0,51 % | 30 Prozent-Rallye voraus?: Hier ist Siemens Healthineers Weltspitze! Analysten sehen großen Kurssprung | © Foto: Daniel Karmann/dpa Der November könnte für Siemens Healthineers einige wichtige Weichenstellungen bedeuten. Auch die Aktie könnte dann endlich wieder Fahrt aufnehmen, meinen die Analysten der... ► Artikel lesen  | |
| GERRESHEIMER | 26,660 | -3,41 % | Gerresheimer: Nächster Paukenschlag - CEO-Wechsel! | Am Dienstagnachmittag baut die Aktie des Spezialverpackungsherstellers Gerresheimer die Kursverluste zeitweise weiter aus. Wie das Unternehmen jüngst bekanntgab, wird CEO Dietmar Siemssen zum 01. November... ► Artikel lesen  | |
| CARL ZEISS MEDITEC | 43,000 | -2,05 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec mit einem Kursziel von 35,10 Euro auf "Underweight" belassen. Vor den am 11. Dezember anstehenden Quartalszahlen lägen seine... ► Artikel lesen  | |
| UNITEDHEALTH | 289,50 | -0,12 % | Buffetts neue Wette: UnitedHealth überrascht mit Gewinn - das Comeback nimmt Fahrt auf! | © Foto: SOPA Images - Sipa USADer US-Gesundheitsriese steckt mitten in einem Umbruch, und sendet mit einer Prognoseerhöhung erste Hoffnungssignale. Seit Warren Buffett investiert ist, ist auch die Aktie... ► Artikel lesen  | |
| BOSTON SCIENTIFIC | 85,80 | +0,23 % | BOSTON SCIENTIFIC CORP - 10-Q, Quarterly Report | ||
| HIMS & HERS HEALTH | 38,750 | +0,57 % | Gesundheit als Milliardenmarkt: PanGenomic Health, Hims & Hers, WW International | Immer mehr Menschen kümmern sich proaktiv um ihre Gesundheit - Vorsorge und Selbstfürsorge liegen im Trend. Laut aktuellen Studien von McKinsey ist die globale Wellness-Branche inzwischen rund 2 Billionen... ► Artikel lesen  | |
| BRIGHTSPRING HEALTH SERVICES | 33,480 | +1,33 % | BrightSpring Health Services GAAP EPS of $0.17 misses by $0.15, revenue of $3.33B misses by $20M | ||
| CLEARPOINT NEURO | 18,990 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen  | |
| ALIGNMENT HEALTHCARE | 16,830 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen  | |
| PROCEPT BIOROBOTICS | 34,510 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen  | |
| GENEDX | 138,25 | 0,00 % | GeneDx raises 2025 revenue guidance to $428M amid accelerating exome and genome test growth | ||
| KINDLY MD | 0,891 | 0,00 % | KindlyMD, Inc: KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility | First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasury Financing Structure SALT LAKE CITY, UTAH / ACCESS Newswire / October... ► Artikel lesen  | |
| ESSILORLUXOTTICA | 317,50 | +0,06 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für EssilorLuxottica von 305 auf 340 Euro angehoben und die Einstufung auf "Outperform" belassen. Analystin Piral Dadhania traut... ► Artikel lesen  |